Mabthera and leukopenia Patient Reports February 12, 2012
Mabthera Side Effects Report #6077387-X
Mabthera side effect was reported by a Health Professional from UNITED KINGDOM on Jan 29, 2009. Male patient, 29 years of age, was diagnosed with transplant rejection and was treated with Mabthera. After drug was administered, patient experienced the following side effects: leukopenia. Mabthera dosage: 500 MG, 2/WEEK. During the same period patient was treated with THYMOGLOBULIN. Patient recovered.
Mabthera Side Effects Report #6085704-X
Mabthera side effect was reported by a Health Professional from UNITED KINGDOM on Feb 15, 2009. Male patient, 29 years of age, was diagnosed with transplant rejection and was treated with Mabthera. After drug was administered, patient experienced the following side effects: leukopenia. Mabthera dosage: 500 MG, 2/WEEK. During the same period patient was treated with THYMOGLOBULIN. Patient recovered.
Mabthera Side Effects Report #5711985-5
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Apr 09, 2008. Female patient, 30 years of age, was diagnosed with systemic lupus erythematosus and was treated with Mabthera. After drug was administered, patient experienced the following side effects: leukopenia. Mabthera dosage: unknown. During the same period patient was treated with OMEPRAZOLE, CYCLOPHOSPHAMIDE, POTASSIUM WITH FUROSEMIDE, ATENOLOL, CYMBALTA, METHADONE. Patient recovered.
Mabthera Side Effects Report #5717117-1
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 15, 2008. Female patient, 14 years of age, was diagnosed with systemic lupus erythematosus and was treated with Mabthera. After drug was administered, patient experienced the following side effects: leukopenia, pyrexia, thrombocytopenia. Mabthera dosage: 500 MG, 1/WEEK. During the same period patient was treated with HYDROXYCHLOROQUINE SULPHATE, VOLTAREN. Patient was hospitalized. Patient recovered.
Mabthera Side Effects Report #5731086-X
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 28, 2008. Female patient, 14 years of age, was diagnosed with systemic lupus erythematosus and was treated with Mabthera. After drug was administered, patient experienced the following side effects: leukopenia, pyrexia, rash macular, thrombocytopenia. Mabthera dosage: 500 MG, 1/WEEK. During the same period patient was treated with HYDROXYCHLOROQUINE SULPHATE, VOLTAREN. Patient was hospitalized. Patient recovered.
Mabthera Side Effects Report #5952420-1
Mabthera side effect was reported by a Consumer or non-health professional from FINLAND on Oct 30, 2008. Female patient, 30 years of age, was diagnosed with rheumatoid arthritis
and was treated with Mabthera. After drug was administered, patient experienced the following side effects: leukopenia, thrombocytopenia, urticaria. Mabthera dosage: 1000 MG/KG, UNK. During the same period patient was treated with AZATHIOPRINE, MEDROL. Patient was hospitalized. Patient recovered.Mabthera Side Effects Report #5368519-7
Mabthera side effect was reported by a Physician from UNITED KINGDOM on June 15, 2007. Female patient, weighting 178.6 lb, was diagnosed with rheumatoid arthritis
and was treated with Mabthera. After drug was administered, patient experienced the following side effects: alveolitis, leukopenia, lymphocytosis, pyrexia. Mabthera dosage: unknown. During the same period patient was treated with CORTISONE ACETATE, METHOTREXATE, DECORTIN H. Patient was hospitalized. Patient recovered.Mabthera Side Effects Report #4669461-7
Mabthera side effect was reported by a Health Professional from on May 12, 2005. Male patient, 56 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: b-cell lymphoma stage iv, back pain
, bone marrow disorder, febrile neutropenia, intervertebral disc protrusion, leukopenia, malignant neoplasm progression, multi-organ failure. Mabthera dosage: 500 MG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with ZEVALIN, YTRACIS, FILGRASTIM, CEFTRIAXONE, CLINDAMYCIN HYDROCHLORIDE, LEVOFLOXACIN, FLUCONAZOLE. Patient was hospitalized. Patient died.Mabthera Side Effects Report #4663290-6
Mabthera side effect was reported by a Physician from on May 03, 2005. Female patient, 53 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: anaemia, leukopenia, neutropenia. Mabthera dosage: 375 MG/M2, INTRAVENOUS. During the same period patient was treated with IFOSFAMIDE, METHOTREXATE, ETOPOSIDE. Patient recovered.
Mabthera Side Effects Report #4713413-5
Mabthera side effect was reported by a Physician from DOMINICAN REPUBLIC on June 22, 2005. Female patient, 53 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: anaemia, leukopenia, neutropenia. Mabthera dosage: 375 MG/M2, INTRAVENOUS. During the same period patient was treated with IFOSFAMIDE, METHOTREXATE, ETOPOSIDE. Patient recovered.
Mabthera Side Effects Report #5055919-8
Mabthera side effect was reported by a Physician from SPAIN on July 06, 2006. Female patient, 52 years of age, weighting 167.6 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: leukopenia, neutropenia. Mabthera dosage: 670 MG, Q3W, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, QUINAPRIL. Patient was hospitalized. Patient recovered.
Mabthera Side Effects Report #4744281-3
Mabthera side effect was reported by a Physician from GERMANY on July 27, 2005. Female patient, 52 years of age, weighting 165.3 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: blood immunoglobulin g decreased, hepatic necrosis, hepatitis
, leukopenia, opportunistic infection, splenomegaly, thrombocytopenia, viral infection
. Mabthera dosage: 675 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, ETOPOSIDE, VINCRISTINE SULPHATE, PREDNISONE. Patient was hospitalized. Patient recovered.Mabthera Side Effects Report #5139771-8
Mabthera side effect was reported by a Physician from GERMANY on Oct 10, 2006. Female patient, 47 years of age, weighting 112.4 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: atelectasis, bronchopulmonary aspergillosis, leukopenia, neutropenia, oedema peripheral, pleural effusion, sinus tachycardia. Mabthera dosage: 630 MG, INTRAVENOUS. During the same period patient was treated with IFOSFAMIDE, METHOTREXATE, ETOPOSIDE. Patient was hospitalized. Patient recovered.
Mabthera Side Effects Report #4825052-6
Mabthera side effect was reported by a Physician from GERMANY on Oct 26, 2005. Female patient, 40 years of age, weighting 119.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: alveolitis, bronchoalveolar lavage abnormal, candidiasis, hypoxia, leukopenia, pneumocystis jiroveci pneumonia, respiratory failure. Mabthera dosage: 375 MG/KG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.
Mabthera Side Effects Report #4891923-8
Mabthera side effect was reported by a Physician from GERMANY on Jan 09, 2006. Female patient, 40 years of age, weighting 119.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: blood cholesterol increased, bone marrow failure, candidiasis, cholelithiasis, leukopenia, lymphadenopathy, neutrophil percentage increased, platelet count decreased, pneumocystis jiroveci pneumonia. Mabthera dosage: 375 MG/KG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, METHOTREXATE, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Mabthera Side Effects Report #4898554-4
Mabthera side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Jan 18, 2006. Female patient, 33 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, leukopenia. Mabthera dosage: 375 MG/M2,. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient recovered.
Mabthera Side Effects Report #5821935-9
Mabthera side effect was reported by a Physician from UNITED KINGDOM on July 09, 2008. Male patient was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: acute coronary syndrome, leukopenia. Mabthera dosage: unknown. During the same period patient was treated with ENDOXAN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.
Mabthera Side Effects Report #4932237-7
Mabthera side effect was reported by a Physician from EL SALVADOR on Feb 14, 2006. Female patient was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: anaemia, headache
, leukopenia, neutropenia. Mabthera dosage: unknown. During the same period patient was treated with ETOPOSIDE, METHYLPREDNISOLONE, HIGH DOSE ARA, CISPLATIN. Patient died.Mabthera Side Effects Report #5812176-X
Mabthera side effect was reported by a Physician from UNITED KINGDOM on July 04, 2008. Female patient was diagnosed with multiple sclerosis
and was treated with Mabthera. After drug was administered, patient experienced the following side effects: anaemia, leukopenia, tuberculin test positive. Mabthera dosage: unknown. During the same period patient was treated with CORTISONE, NITROFURANTOIN. Patient recovered.Mabthera Side Effects Report #4776420-2
Mabthera side effect was reported by a Physician from FRANCE on Sept 08, 2005. Female patient, 67 years of age, was diagnosed with mantle cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: leukopenia, neutropenia. Mabthera dosage: unknown. Patient recovered.
Mabthera Side Effects Report #4621113-5
Mabthera side effect was reported by a Physician from on Mar 15, 2005. Female patient, 52 years of age, was diagnosed with mantle cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: anaemia, bone marrow depression, leukopenia, macrocytosis, neutropenia, thrombocytopenia. Mabthera dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE. Patient recovered.
Mabthera Side Effects Report #4842919-3
Mabthera side effect was reported by a Physician from IRELAND on Nov 21, 2005. Male patient, 67 years of age, was diagnosed with lymphoma
and was treated with Mabthera. After drug was administered, patient experienced the following side effects: leukopenia, neutrophil count decreased. Mabthera dosage: 375 MG/M2, 1/MONTH, INTRAVENOUS. Patient was hospitalized. Patient recovered.Mabthera Side Effects Report #4866036-1
Mabthera side effect was reported by a Physician from IRELAND on Dec 08, 2005. Male patient, 67 years of age, was diagnosed with lymphoma
and was treated with Mabthera. After drug was administered, patient experienced the following side effects: leukopenia, neutrophil count decreased. Mabthera dosage: 375 MG/M2, 1/MONTH, INTRAVENOUS. Patient was hospitalized. Patient recovered.Mabthera Side Effects Report #4716821-1
Mabthera side effect was reported by a Health Professional from ITALY on June 22, 2005. Male patient, 61 years of age, weighting 174.2 lb, was diagnosed with lymphoma
and was treated with Mabthera. After drug was administered, patient experienced the following side effects: leukopenia, neutropenia. Mabthera dosage: 700 MG, Q28D, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, MITOXANTRONE, DEXAMETHASONE, SULFAMETHOXAZOLE, WARFARIN, DELORAZEPAM, AMIODARONE, LOSARTAN. Patient recovered.Mabthera Side Effects Report #4950582-6
Mabthera side effect was reported by a Physician from EL SALVADOR on Mar 07, 2006. Female patient was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: anaemia, headache
, leukopenia, neutropenia, thrombocytopenia. Mabthera dosage: unknown. During the same period patient was treated with ETOPOSIDE, METHYLPREDNISOLONE, HIGH DOSE ARA, CISPLATIN. Patient died.Mabthera Side Effects Report #4954458-X
Mabthera side effect was reported by a Physician from EL SALVADOR on Mar 06, 2006. Female patient was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: anaemia, diffuse large b-cell lymphoma, headache
, leukopenia, malignant neoplasm progression, neutropenia, thrombocytopenia. Mabthera dosage: unknown. During the same period patient was treated with ETOPOSIDE, METHYLPREDNISOLONE, HIGH DOSE ARA, CISPLATIN. Patient died on 11/01/2005.Mabthera Side Effects Report #4764397-5
Mabthera side effect was reported by a Health Professional from BELGIUM on Aug 25, 2005. Female patient, 74 years of age, weighting 123.5 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: anaemia, aplasia, leukopenia, thrombocytopenia. Mabthera dosage: 375 MG/M2, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, ATACAND, LIPITOR. Patient was hospitalized. Patient recovered.
Mabthera Side Effects Report #4726574-9
Mabthera side effect was reported by a Health Professional from GERMANY on July 13, 2005. Male patient, 71 years of age, weighting 178.6 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: conjunctivitis, dacryostenosis acquired, leukopenia. Mabthera dosage: 1000 MG, X6, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, ALLOPURINOL, ASPIRIN. Patient was hospitalized. Patient recovered.
Mabthera Side Effects Report #4815719-8
Mabthera side effect was reported by a Physician from GERMANY on Oct 17, 2005. Male patient, 71 years of age, weighting 178.6 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: conjunctivitis, dacryostenosis acquired, leukopenia. Mabthera dosage: 1000 MG, X6, INTRAVENOUS. During the same period patient was treated with FLUDARA, CYCLOPHOSPHAMIDE, ALLOPURINOL, ASPIRIN. Patient was hospitalized. Patient recovered.
Mabthera Side Effects Report #4644296-X
Mabthera side effect was reported by a Physician from on Apr 12, 2005. Male patient, 68 years of age, weighting 196.2 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: leukopenia, pneumonia
. Mabthera dosage: 375 MG/M2, Q4W, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, CYNT, BAYOTENSIN. Patient was hospitalized. Patient recovered.Mabthera Side Effects Report #4685238-0
Mabthera side effect was reported by a Physician from on May 20, 2005. Male patient, 68 years of age, weighting 196.2 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: leukopenia, pneumonia
. Mabthera dosage: 375 MG/M2, Q4W, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, LEVOTHYROXINE, CYNT, BAYOTENSIN. Patient was hospitalized. Patient recovered.Mabthera Side Effects Report #4865819-1
Mabthera side effect was reported by a Physician from GERMANY on Dec 09, 2005. Male patient, 68 years of age, weighting 196.2 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: body temperature increased, emphysema, fibrosis, leukopenia, lung infiltration, lymphoma
, mucosal inflammation, pneumonia
, pulmonary congestion. Mabthera dosage: 375 MG/M2, Q4W, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, LEVOTHYROXINE, CYNT, BAYOTENSIN. Patient was hospitalized. Patient recovered.Mabthera Side Effects Report #5023748-7
Mabthera side effect was reported by a Physician from GERMANY on May 31, 2006. Male patient, 68 years of age, weighting 196.2 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: emphysema, leukopenia, mucosal inflammation, pneumonia
, pulmonary calcification, pulmonary congestion, pulmonary fibrosis
, sinus disorder, sinus polyp. Mabthera dosage: 375 MG/M2., Q4W INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.Mabthera Side Effects Report #5244830-5
Mabthera side effect was reported by a Health Professional from GERMANY on Feb 02, 2007. Male patient, 65 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: leukopenia, transitional cell carcinoma. Mabthera dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.
Mabthera Side Effects Report #4821956-9
Mabthera side effect was reported by a Health Professional from GERMANY on Oct 25, 2005. Male patient, 58 years of age, weighting 238.1 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, bone marrow failure, bone marrow toxicity, gamma-glutamyltransferase increased, hyperhidrosis, leukopenia, platelet count decreased, splenomegaly. Mabthera dosage: 500 MG,. During the same period patient was treated with FLUDARABINE, CYCLOPHOSPHAMIDE, COTRIMTE, FUROSEMIDE, ESIDRIX. Patient recovered.
Mabthera Side Effects Report #4825487-1
Mabthera side effect was reported by a Physician from GERMANY on Nov 01, 2005. Male patient, 58 years of age, weighting 238.1 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, bone marrow failure, bone marrow toxicity, gamma-glutamyltransferase increased, hyperhidrosis, leukopenia, spleen disorder, splenomegaly, therapeutic response decreased. Mabthera dosage: 500 MG. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, COTRIMTE, FUROSEMIDE, ESIDRIX, LEVOFLOXACIN, AMPHOMORONAL. Patient recovered.
Mabthera Side Effects Report #4766404-2
Mabthera side effect was reported by a Physician from GERMANY on Aug 31, 2005. Male patient, 50 years of age, weighting 168.7 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: anaemia, febrile neutropenia, leukopenia. Mabthera dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, URALYT, ALLOPURINOL, COTRIMTE. Patient was hospitalized. Patient recovered.
Mabthera Side Effects Report #4659363-4
Mabthera side effect was reported by a Pharmacist from on Apr 27, 2005. Male patient, 43 years of age, weighting 154.3 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: colitis, disease progression, haematocrit decreased, leukopenia, proctitis ulcerative, pyrexia, weight decreased. Mabthera dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, NEUPOGEN, PANTOZOL, DIFLUCAN, CIPROFLOXACIN, ACICLOVIR. Patient was hospitalized. Patient recovered.
Mabthera Side Effects Report #5756173-1
Mabthera side effect was reported by a Physician from UNITED KINGDOM on May 15, 2008. Female patient was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: anaemia, anal fistula, febrile neutropenia, gastric ulcer, leukopenia, pain
, pyrexia. Mabthera dosage: 50 MG/M2, UNK. During the same period patient was treated with FLUDARABINE PHOSPHATE, ACETAMINOPHEN. Patient recovered.Mabthera Side Effects Report #4625805-3
Mabthera side effect was reported by a Pharmacist from on Mar 17, 2005. Male patient, weighting 154.3 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: colitis ulcerative, leukopenia, proctitis, proctocolitis, weight decreased. Mabthera dosage: 375 MG/M2, INTRAVENOUS; 500 MG/M2, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, NEUPOGEN, PANTOZOL, DIFLUCAN, CIPROFLOXACIN, ACICLOVIR. Patient was hospitalized. Patient recovered.
Mabthera Side Effects Report #4661256-3
Mabthera side effect was reported by a Physician from on Apr 27, 2005. Male patient was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: c-reactive protein increased, colitis, haematocrit decreased, leukopenia, neutropenia, platelet count decreased. Mabthera dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.
Mabthera Side Effects Report #4685143-X
Mabthera side effect was reported by a Physician from on May 23, 2005. Male patient, weighting 168.7 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, leukopenia. Mabthera dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, URALYT. Patient was hospitalized. Patient recovered.
Mabthera Side Effects Report #4757121-3
Mabthera side effect was reported by a Physician from GERMANY on Aug 18, 2005. Male patient, weighting 238.1 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: bone marrow depression, leukopenia, platelet count decreased, viral infection
. Mabthera dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, COTRIMTE. Patient recovered.Mabthera Side Effects Report #4764423-3
Mabthera side effect was reported by a Health Professional from GERMANY on Aug 24, 2005. Male patient, weighting 238.1 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: bone marrow depression, bone marrow toxicity, hepatic steatosis, hyperhidrosis, leukopenia, renal cyst, spleen disorder, splenomegaly, viral infection
. Mabthera dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, COTRIMTE, FUROSEMIDE, ESIDRIX. Patient recovered.Mabthera Side Effects Report #4822588-9
Mabthera side effect was reported by a Consumer or non-health professional from GERMANY on Oct 24, 2005. Male patient, weighting 169.8 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: leukopenia. Mabthera dosage: 500 MG, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, ALLOPURINOL, HEPARIN, PREDNISONE, KEVATRIL, PENICILLIN, ZANTIC. Patient was hospitalized. Patient recovered.
Mabthera Side Effects Report #4863925-9
Mabthera side effect was reported by a Physician from GERMANY on Dec 07, 2005. Male patient, weighting 169.8 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: leukopenia. Mabthera dosage: 500 MG, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, ALLOPURINOL, COTRIMTE, BLEOMYCIN, HEPARIN, PREDNISONE, KEVATRIL. Patient was hospitalized. Patient recovered.
Mabthera Side Effects Report #5113390-1
Mabthera side effect was reported by a Physician from FINLAND on Sept 07, 2006. Male patient, 65 years of age, weighting 209.4 lb, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: dyspnoea, escherichia sepsis, hypotonia, hypoxia, infection
, leukopenia, multi-organ failure, nausea
, neutropenia. Mabthera dosage: 840 MG, UNK, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, ACETAMINOPHEN, ONDANESTRON, CETIRIZINE, NEULASTA. Patient was hospitalized. Patient died on 08/27/2006.Mabthera Side Effects Report #5722722-2
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Mar 26, 2008. Female patient was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: leukopenia, myelodysplastic syndrome, thrombocytopenia. Mabthera dosage: 630 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE, VINCRISTINE. Patient recovered.
Mabthera Side Effects Report #5869201-X
Mabthera side effect was reported by a Physician from GERMANY on Aug 26, 2008. Male patient, 67 years of age, was diagnosed with anti-neutrophil cytoplasmic antibody positive vasculitis and was treated with Mabthera. After drug was administered, patient experienced the following side effects: leukopenia. Mabthera dosage: 375 MG/M2, X4. During the same period patient was treated with RANITIDINE, CLEMASTINE FUMARATE, PREDNISOLONE, TRIMETHOPRIM. Patient recovered.
Mabthera Side Effects Report #5898986-1
Mabthera side effect was reported by a Physician from GERMANY on Sept 17, 2008. Male patient, 67 years of age, was diagnosed with anti-neutrophil cytoplasmic antibody positive vasculitis and was treated with Mabthera. After drug was administered, patient experienced the following side effects: leukopenia. Mabthera dosage: 375 MG/M2, X4. During the same period patient was treated with RANITIDINE, CLEMASTINE FUMARATE, PREDNISOLONE, TRIMETHOPRIM. Patient recovered.
Mabthera Side Effects Report #5869135-0
Mabthera side effect was reported by a Physician from GERMANY on Aug 26, 2008. Male patient was diagnosed with anti-neutrophil cytoplasmic antibody positive vasculitis and was treated with Mabthera. After drug was administered, patient experienced the following side effects: leukopenia, pneumonia
. Mabthera dosage: 375 MG/M2, X4. During the same period patient was treated with RANITIDINE, CLEMASTINE FUMARATE, PREDNISOLONE. Patient died.Mabthera Side Effects Report #5869145-3
Mabthera side effect was reported by a Physician from GERMANY on Aug 26, 2008. Female patient was diagnosed with anti-neutrophil cytoplasmic antibody positive vasculitis, pain
and was treated with Mabthera. After drug was administered, patient experienced the following side effects: leukopenia. Mabthera dosage: 375 MG/M2, X4. During the same period patient was treated with RANITIDINE, CLEMASTINE FUMARATE, PREDNISOLONE, METAMIZOLE, MYCOPHENOLATE MOFETIL. Patient recovered.Mabthera Side Effects Report #5898231-7
Mabthera side effect was reported by a Physician from GERMANY on Sept 17, 2008. Female patient was diagnosed with anti-neutrophil cytoplasmic antibody positive vasculitis, pain
and was treated with Mabthera. After drug was administered, patient experienced the following side effects: leukopenia. Mabthera dosage: 375 MG/M2, X4. During the same period patient was treated with RANITIDINE, CLEMASTINE FUMARATE, PREDNISOLONE, METAMIZOLE, MYCOPHENOLATE MOFETIL. Patient recovered.Mabthera Side Effects Report #5346524-4
Mabthera side effect was reported by a Physician from UNITED KINGDOM on May 31, 2007. Male patient, 49 years of age, was treated with Mabthera. After drug was administered, patient experienced the following side effects: leukocytosis, leukopenia, lymphocytosis, pyrexia. Mabthera dosage: unknown. During the same period patient was treated with CORTISONE ACETATE, METHOTREXATE. Patient recovered.
Mabthera and leukopenia 